W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 10 700 KRW 1.33% Market Closed
Market Cap: ₩163.4B

Operating Margin

5%
Current
Declining
by 5.9%
vs 3-y average of 10.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5%
=
Operating Income
₩12.8B
/
Revenue
₩256.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5%
=
Operating Income
₩12.8B
/
Revenue
₩256.3B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Whanin Pharm Co Ltd
KRX:016580
174.1B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
63rd
Based on 2 615 companies
63rd percentile
5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Whanin Pharm Co Ltd
Glance View

Market Cap
163.4B KRW
Industry
Pharmaceuticals

Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. The company is headquartered in Seoul, Seoul. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company’s products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The firm also involves in the real estate rental business.

Whanin Pharm Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5%
=
Operating Income
₩12.8B
/
Revenue
₩256.3B
What is Whanin Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Whanin Pharm Co Ltd is 5%, which is below its 3-year median of 10.9%.

How has Operating Margin changed over time?

Over the last 3 years, Whanin Pharm Co Ltd’s Operating Margin has decreased from 14.5% to 5%. During this period, it reached a low of 5% on Oct 30, 2025 and a high of 15% on Dec 31, 2022.

Back to Top